Literature DB >> 28846380

Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library.

Barbara Männel1, Mariama Jaiteh2, Alexey Zeifman2, Alena Randakova1, Dorothee Möller1, Harald Hübner1, Peter Gmeiner1, Jens Carlsson2.   

Abstract

Functionally selective ligands stabilize conformations of G protein-coupled receptors (GPCRs) that induce a preference for signaling via a subset of the intracellular pathways activated by the endogenous agonists. The possibility to fine-tune the functional activity of a receptor provides opportunities to develop drugs that selectively signal via pathways associated with a therapeutic effect and avoid those causing side effects. Animal studies have indicated that ligands displaying functional selectivity at the D2 dopamine receptor (D2R) could be safer and more efficacious drugs against neuropsychiatric diseases. In this work, computational design of functionally selective D2R ligands was explored using structure-based virtual screening. Molecular docking of known functionally selective ligands to a D2R homology model indicated that such compounds were anchored by interactions with the orthosteric site and extended into a common secondary pocket. A tailored virtual library with close to 13 000 compounds bearing 2,3-dichlorophenylpiperazine, a privileged orthosteric scaffold, connected to diverse chemical moieties via a linker was docked to the D2R model. Eighteen top-ranked compounds that occupied both the orthosteric and allosteric site were synthesized, leading to the discovery of 16 partial agonists. A majority of the ligands had comparable maximum effects in the G protein and β-arrestin recruitment assays, but a subset displayed preference for a single pathway. In particular, compound 4 stimulated β-arrestin recruitment (EC50 = 320 nM, Emax = 16%) but had no detectable G protein signaling. The use of structure-based screening and virtual libraries to discover GPCR ligands with tailored functional properties will be discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28846380     DOI: 10.1021/acschembio.7b00493

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  18 in total

1.  D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine.

Authors:  Yudao Shen; John D McCorvy; Michael L Martini; Ramona M Rodriguiz; Vladimir M Pogorelov; Karen M Ward; William C Wetsel; Jing Liu; Bryan L Roth; Jian Jin
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

2.  Rational design of agonists for bitter taste receptor TAS2R14: from modeling to bench and back.

Authors:  Antonella Di Pizio; Lukas A W Waterloo; Regine Brox; Stefan Löber; Dorothee Weikert; Maik Behrens; Peter Gmeiner; Masha Y Niv
Journal:  Cell Mol Life Sci       Date:  2019-06-24       Impact factor: 9.261

Review 3.  Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders.

Authors:  Richard M Kostrzewa; Karolina Wydra; Malgorzata Filip; Cynthia A Crawford; Sanders A McDougall; Russell W Brown; Dasiel O Borroto-Escuela; Kjell Fuxe; Raul R Gainetdinov
Journal:  J Pharmacol Exp Ther       Date:  2018-06-19       Impact factor: 4.030

4.  Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance.

Authors:  Ankita Punetha; Keith D Green; Atefeh Garzan; Nishad Thamban Chandrika; Melisa J Willby; Allan H Pang; Caixia Hou; Selina Y L Holbrook; Kyle Krieger; James E Posey; Tanya Parish; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  RSC Med Chem       Date:  2021-10-05

5.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

Review 6.  Trends in application of advancing computational approaches in GPCR ligand discovery.

Authors:  Siyu Zhu; Meixian Wu; Ziwei Huang; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-27

7.  Property-Unmatched Decoys in Docking Benchmarks.

Authors:  Reed M Stein; Ying Yang; Trent E Balius; Matt J O'Meara; Jiankun Lyu; Jennifer Young; Khanh Tang; Brian K Shoichet; John J Irwin
Journal:  J Chem Inf Model       Date:  2021-01-25       Impact factor: 4.956

8.  Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?

Authors:  Jon Kapla; Ismael Rodríguez-Espigares; Flavio Ballante; Jana Selent; Jens Carlsson
Journal:  PLoS Comput Biol       Date:  2021-05-13       Impact factor: 4.475

Review 9.  A practical guide to large-scale docking.

Authors:  Brian J Bender; Stefan Gahbauer; Andreas Luttens; Jiankun Lyu; Chase M Webb; Reed M Stein; Elissa A Fink; Trent E Balius; Jens Carlsson; John J Irwin; Brian K Shoichet
Journal:  Nat Protoc       Date:  2021-09-24       Impact factor: 17.021

Review 10.  In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery.

Authors:  Lauro Ribeiro de Souza Neto; José Teófilo Moreira-Filho; Bruno Junior Neves; Rocío Lucía Beatriz Riveros Maidana; Ana Carolina Ramos Guimarães; Nicholas Furnham; Carolina Horta Andrade; Floriano Paes Silva
Journal:  Front Chem       Date:  2020-02-18       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.